D-Wave Quantum price target raised to $18 from $12 at Roth Capital

Roth Capital raised the firm's price target on D-Wave Quantum (QBTS) to $18 from $12 and keeps a Buy rating on the shares. The firm believes D-Wave has gained customer market interest in recent months and in doing so is expanding its revenue potential across both hosted service and hardware sale opportunities. Roth expects both commercial and AI-related customer interest to intensify in the coming quarters.
Confident Investing Starts Here:

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

3 hours ago

• Yahoo

Roth Capital Hikes Verona Pharma's (VRNA) Price Target to $116 On COPD Market Prospects

Verona Pharma plc (NASDAQ:VRNA) is one of the 10 biotech stocks screaming a buy. On June 17, Roth Capital increased its price target to $116 from $92 while reiterating a Buy rating. The adjustment follows remarks by Dr Frank Sciurba, who discussed unmet chronic obstructive pulmonary disease needs. A close up of a researcher in a laboratory, examining a new biopharmaceutical drug used to treat resistant bacterial infections. The doctor shared positive insights on the company's product Ohtuvayre, highlighting its complementary role in newly approved biologics. According to Roth Capital, the enhanced understanding of Verona Pharma's Ohtuvayre's distinctive efficacy and risk profile is already sparking greater interest among investors. Consequently, the research firm raised its price target in response to the increased attention and appreciation of Verona Pharma's offering. The research firm remains bullish about the company's growth potential. Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases. It focuses on developing treatments for chronic obstructive pulmonary disease (COPD). They are known for their product, ensifentrine, an investigational, inhaled, small molecule that acts as a dual inhibitor of phosphodiesterase 3 and 4 (PDE3 and PDE4), combining bronchodilator and anti-inflammatory properties. While we acknowledge the potential of VRNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Software Stocks to Buy Now and 11 Must-Buy AI Stocks Analysts Are Betting On. Disclosure: None. Sign in to access your portfolio

Forbes

6 hours ago

• Forbes

This Rideable Robot Is A Man-Made Horse Powered By Hydrogen

It had to happen. One day, humans had to attempt to make their own horse. Or a machine as close as can be to a rideable Rottweiler. Boasting the combined attributes of a horse, a mountain lion and a motorcycle, here it is—the Kawasaki Corleo concept. That's right, it'll be a while before you can actually buy one. Check out the video below. According to the company, one day deep in the R&D department, someone dared to ask, 'What if we put legs on an all-terrain vehicle?' So, working outside of their comfort zone, engineers created the Corleo. The resulting vehicle incorporates the company's vision of mobility in 2050, where instinct, technology and the natural environment move in sync. Or at least, that's what Kawasaki Heavy Industries says. Corleo is a 4-legged rideable robot targeting a 2050 future Unveiled recently at the Expo 2025 Osaka in Japan, the Corleo is a revolutionary off-road personal mobility vehicle—a rideable robot propelled by four legs and powered by an engine fueled with hydrogen. While Kawasaki did actually unveil this real-life concept, it was the brand's computer-generated video that has generated intense interest online. Making the Corleo look like a hoot to ride, the imagery portrays a rideable four-legged robot that comes across as an advanced version of Boston Dynamics' Spot —the dog-like robot mixed with the fun of Luke Skywalker's Landspeeder cruiser. Having racked up over 1.1 million views so far, the CGI video shows the Corleo galloping through a thick forest, frolicking across a field, leaping across a small gorge and trotting across a snowy outcrop in a landscape mimicking scenes from Lord of the Rings. Corleo employs independently articulating legs As far as actual riding goes, Kawasaki says that the Corleo mimics the responsive feel of an ATV or even a motorcycle, but instead of using wheels, it employs independently articulating legs with swing arms that absorb impact and shocks and adapt to uneven terrain. Each leg is fitted with a hoof made from slip-resistant rubber, split left-to-right to adapt to different surfaces like grass, gravel, and rock. This four-legged construction maintains balance and stability as it keeps the rider's body in an upright forward-looking posture, even when climbing steps. Corleo employs some clever design ideas, including independent legs, a hydrogen engine and steering through weight shifts using sensors in the stirrups and handlebars. The rear leg unit can swing up and down independently from the front leg unit, allowing it to absorb shocks during walking and running. A 150cc hydrogen engine produces electricity to propel the leg-mounted drive units, with rear-mounted hydrogen canisters supplying fuel to deliver low emissions and silent operation. An onboard GPS navigation screen guides riders by mapping a path up or down a hill, while also ensuring the rider's center of gravity, and hydrogen fuel levels. "While preserving the joy of riding, the vehicle continually monitors the rider's movements to achieve a reassuring sense of unity between human and machine," Kawasaki said.

Yahoo

16 hours ago

• Yahoo

Groupon price target raised to $39 from $35 at Northland

Northland analyst Bobby Brooks raised the firm's price target on Groupon (GRPN) to $39 from $35 and keeps an Outperform rating on the shares after the company announced what the firm calls 'an opportunistic and proactive financing transaction.' The newly issued 2030 notes meaningfully simplifies the company's capital structure and provides more flexibility, the analyst tells investors. This deal removes any balance sheet overhangs and is a continuation of the company's shift from 'defense to offense,' the analyst added. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on GRPN: Disclaimer & DisclosureReport an Issue Groupon price target raised to $47 from $33 at Roth Capital Groupon Announces New Convertible Senior Notes Issuance Groupon price target raised to $35 from $30 at Northland Groupon price target raised to $33 from $27 at Roth Capital Short Report: Bears questioning Cinemark, Groupon rallies Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data